Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06835504
PHASE3

Morphine or Ketamine for Analgesia

Sponsor: Columbia University

View on ClinicalTrials.gov

Summary

Pain is common in children presenting to the emergency department but is frequently undertreated, leading to both short- and long-term consequences. Morphine is the standard treatment for children with moderate to severe acute pain, but its use is associated with serious side effects and caregiver and clinician concerns related to opioid administration. The investigators aim to determine if sub-dissociative ketamine is non-inferior to morphine for treating acute pain and a preferable alternative for treating acute pain in children because of its more favorable side effect profile and potential long-term benefits related to pain-related function, analgesic use/misuse, and mental and behavioral health outcomes.

Official title: Efficacy of Intravenous Sub-Dissociative Ketamine Versus Intravenous Morphine in Children With Acute Pain

Key Details

Gender

All

Age Range

6 Years - 17 Years

Study Type

INTERVENTIONAL

Enrollment

1010

Start Date

2026-05-01

Completion Date

2029-10-31

Last Updated

2026-01-26

Healthy Volunteers

No

Interventions

DRUG

Ketamine hydrochloride

Sub-dissociative ketamine, IV

DRUG

Morphine sulphate

Morphine, IV

Locations (8)

Children's Hospital Los Angeles

Los Angeles, California, United States

UC Davis Children's Hospital

Sacramento, California, United States

Nemours Children's Hospital

Wilmington, Delaware, United States

Arthur M. Blank Hospital

Atlanta, Georgia, United States

NewYork Presbyterian Morgan Stanley Children's Hospital

New York, New York, United States

UPMC Children's Hospital of Pittsburgh

Pittsburgh, Pennsylvania, United States

Seattle Children's Hospital

Seattle, Washington, United States

Children's Wisconsin

Milwaukee, Wisconsin, United States